|

Cabazitaxel 60 mg Solution for Injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Karolinska Institutet1

Indications

  • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)1
  • Metastatic Castration-resistant Prostate Cancer, mCRPC1
  • Cancer1

Other1 trial

ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.